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http:WHAT THIS PAPER ADDS
In a previously unscreened population, computed tomography colonography was used as a surrogate for an
abdominal ultrasound, at no extra cost or increased risk of radiation, to determine the prevalence of abdominal
aortic aneurysm (AAA). The prevalence of AAA in men was similar to that in published randomised AAA
screening trials. Knowledge of contemporary AAA prevalence in women and octogenariansdtwo groups that
have not been included in screening programmesdis extended. The data presented highlight the high preva-
lence of AAA, particularly in the elderly, and the challenges that health services might encounter from the AAA
burden.Objective/Background: There is compelling level 1 evidence in support of screening men for abdominal aortic
aneurysm (AAA) to reduce AAA mortality. However, New Zealand (NZ) lacks data on AAA prevalence, and national
screening has not been implemented. The aim of this study was to determine the prevalence of AAA in a
population undergoing a computed tomography colonography (CTC) for gastrointestinal symptoms.
Methods: This was an observational study; all consecutive CTCs performed in three regions of the South Island of
NZ over a 4 year period were reviewed. Data on abdominal and thoracic aorta diameters 30 mm, and iliac and
femoral aneurysms 20 mm were recorded. Previous aortic surgical grafts or endovascular stents were also
documented. Demographics, survival, and AAA related outcomes were collected and used for analysis.
Results: Included were 4,893 scans on 4,644 patients (1,933 men [41.6%], 2,711 women [58.4%]) with a median
age of 69.3 years (range 17.0e97.0 years). There were 309 scans on 289 patients (75.4% men) who had either an
aneurysm or a previous aortic graft with a median age of 79.6 years (range 57.0e96.0 years). Of these, 223 had a
native AAA 30 mm. The prevalence of AAA rose with age from 1.3% in men aged 55e64 years, to 9.1% in 65e
74 year olds, 16.8% in 75e84 year olds, and 22.0% in 85 year olds. The corresponding ﬁgures in women were
0.4%, 2%, 3.9%, and 6.2%, respectively.
Conclusion: In this observational study, the prevalence of AAA was high and warrants further evaluation. The
results acquired help to deﬁne a population that may beneﬁt from a national AAA screening programme.
 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Abdominal aortic aneurysm (AAA) screening using an
abdominal ultrasound (US) has been shown to reduce AAA
mortality in asymptomatic men over the age of 65 years.1
The uptake of national screening programmes has been
slow for several reasons, including changing epidemiology,2,3rresponding author.
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//dx.doi.org/10.1016/j.ejvs.2015.04.023lack of funding or awareness, and varying AAA prevalence
among different populations and ethnicities. In New Zealand
(NZ), the true prevalence of AAA is unknown and detection
still relies on incidental ﬁndings from radiological modalities
and referrals from other physicians. The global AAA burden
has changed between 1990 and 2010. However, the inci-
dence of AAA has been highest in Australasia, despite a
decrease in trends in NZ.4
In Canterbury, NZ, a pathway to triage patients with
gastrointestinal (GI) symptoms was introduced in 2008.
Depending on clinical symptoms, physical examination
ﬁndings, family history, and laboratory results, a high score
directs referrals to an endoscopic colonoscopy, while a
low score directs referrals to a computed tomography
200 M. Khashram et al.colonography (CTC) ﬁrst approach.5 Owing to constraints on
the public health system in providing colonoscopy for
symptomatic patients, the use of CTC for the detection of
colorectal diseases and colonic surveillance has gained
popularity in NZ as an alternative to optical colonoscopy. It
has also been used when colonoscopy could not be
completed and in the surveillance of colonic diseases. A CTC
(also referred to as “virtual colonoscopy”) is a non-invasive,
low dose CT that assesses the entire colon by inﬂating air
via the rectum to allow distension of the colon and visu-
alisation of colonic pathology. Other potential advantages of
CTC include visualisation of extra-colonic pathologies such
as AAA at no additional cost or radiation risk. CT also per-
mits assessment of the entire aorta (usually the descending
thoracic aorta to femoral bifurcation) and precise mea-
surement of the aortic wall without hindrance from bowel
gas or obesity.
Previous model studies revealed that dual screening for
colorectal cancer (CRC) and AAA using CTC was more cost
effective in a hypothetical population when compared with
optical colonoscopy and an abdominal aortic US.6,7 While
randomised trials of AAA screening used US to measure the
abdominal aorta, in the absence of a national US screening
programme, the aim of this study was to use CTC as a
surrogate for US to document the prevalence of AAA in a
population undergoing CTC for GI symptoms.
METHODS
This was a retrospective observational study. From 1
January 2009 to 1 April 2013 all consecutive CTCs per-
formed in the Canterbury, West Coast, and Timaru regions
of South Island, NZ, were retrieved from the picture
archiving computer system (PACS) database. The retro-
spective nature of the study precluded individual patient
consent. The study was approved by the national Health
and Disability Ethics Committee.
The CTC examination was performed at seven different
centres with similar protocols. A rectal or stomal tube was
inserted for air inﬂation; a helical CT with 2.5 mm slices was
performed in the prone and supine positions, with a large
ﬁeld of view. Intravenous contrast was used if the diagnosis
of malignancy was known, or as indicated clinically. The
presence of a distended distal bowel and rectal or stomal
tube was conﬁrmed to ensure that the scan was a CTC.Measurements
The entire available aorta from the seriesdusually from the
descending aorta into the femoral bifurcationdwas
meticulously assessed. Any dilatation or abnormal change in
aortic calibre triggered aortic measurements of the dilated
segments. Measurements were performed with a digital
magniﬁed viewdat eye level to avoid any parallaxdusing
outer wall to outer wall lengths using ﬁne electronic calli-
pers, also ensuring that the line of measurement passed
through the centre of the aneurysm.8 Maximum short axis
diameters were recorded to 0.1 mm. The presence of a
thoracic and abdominal aorta 30 mm, iliac and femoralarteries 20 mm, and a visceral artery 1.5 mm were
recorded. The presence of previous aortic prosthetic grafts
or endovascular stent grafts was also documented. All
measurements were carried out by the same investigator
(M.K.).
Demographical data for all patients, including dates of
death, deprivation index, and ethnicity, were obtained from
the Ministry of Health’s database. Deprivation index was
deﬁned as the measure of the socioeconomic status of
geographical areas based on 2013 NZ census data, where 1
is least deprived and 10 is most deprived.9 Clinical risk
factors, aneurysm location, colorectal cancer (CRC) diag-
nosis, and causes of death were collected from patients
with aneurysms or previous aortic surgery. CTC radiologist
reports were viewed to determine whether the presence of
aneurysms was commented on and whether patients were
in a AAA surveillance programme. The aneurysm with the
largest diameter was deﬁned as the primary aneurysm;
other aneurysms detected were referred to as secondary.
Estimated predicted life expectancy ﬁgures were obtained
from the NZ life tables 2010e12 (www.stats.govt.nz) for a
ﬁctive population matched to age and sex.10
Preliminary analysis indicated that the continuous
explanatory variables (age and deprivation) were related to
the presence of AAA (binary) on a linear rather than a
logarithmic scale; therefore, linear regression models were
used to calculate unadjusted and adjusted rate differ-
ences.11 Rate ratios were also calculated for categorical
variables using Poisson regression with robust standard
errors due to non-convergence of log binomial models.12
KaplaneMeier methodology was used for survival anal-
ysis, and the log rank test was used for univariate group
comparison. The Cox proportional model was used to
calculate adjusted and unadjusted hazard ratios (HRs) for
variables inﬂuencing survival. Survival data were censored
on 1 October 2014. Statistical signiﬁcance and 95% conﬁ-
dence intervals (CIs) were calculated with an alpha of 0.05.
Statistical analyses were performed using SPSS 22 for Mac
(IBM, Armonk, NY, USA).RESULTS
During the study period, 4,915 CTC scans were performed
on 4,665 patients. Of these scans, 22 were coded on the
PACS database as CTC but when the scans were reviewed,
the CT was not a CTC or the raw axial images were not
stored and were therefore excluded from any further
analysis. Hence, 4,893 scans on 4,644 patients (male: fe-
male ratio ¼ 1.0: 1.4) and a median age of 69.3 years (range
17.0e97.0 years) were reviewed. Excluded from further
analysis were 925 patients aged <55 years old who had no
AAA detected. The median age of the remaining 3,719 in-
dividuals was 72.9 years (range 55.0e97.4 years). The
number of CTC scans performed in the years 2009e12 was
1,039, 1,174, 1,169, and 1,178 scans, respectively.
There were 309 scans on 289 patients who had either an
aneurysm in any location or a previous abdominal aortic
graft repair. The location of aneurysms and abnormal aortas
Table 1. Number of thoracic/abdominal aneurysms 30 mm and
iliac/femoral/visceral aneurysms 20 mm.
Location n
AAA (native) 223
AAA (graft)a 26
Iliac 23
Thoracic 5
Femoral 1
Prosthetic graftb 9 (6 open, 3 EVAR)
Visceral 2
Total 289
Note. AAA ¼ abdominal aortic aneurysm; EVAR ¼ endovascular
aneurysm repair.
a Graft diameter 30 mm.
b Diameter <3 cm.
Table 2. Demographics and baseline characteristics of patients
(n ¼ 223) with abdominal aortic aneurysms (AAAs).
Median age, y (range) 79.7 (57.4e96.2)
Men 166 (74.4)
Ethnicity
NZ European/European 210 (94.2)
Maori 4 (1.8)
Other/unknown 9 (4.0)
Median AAA diameter, cm (range) 3.3 (3.0e9.4)
AAA neck location
Infrarenal 203 (91.0)
Juxtarenal 14 (6.3)
Suprarenal 6 (2.7)
IHDa 113 (50.7)
Statina 139 (62.3)
Hypertensiona 195 (87.4)
COPDa 51 (22.9)
Creatinine (mean  SD) 106.7  34.6
Diabetesa 43 (19.3)
Colorectal cancer 19 (8.5)
Smokingb
Never 49 (22.3)
Ex-smoker 137 (62.6)
Current 33 (15.1)
Deprivation index
1e2 (better SES) 30 (13.5)
3e4 36 (16.1)
5e6 46 (20.6)
7e8 91 (40.8)
9e10 (worse SES) 21 (9.4)
AAA in surveillance 84 (37.6)
Secondary aneurysm 20 (9.0)
AAA reported 158 (70.9)
Note. Data are given as n (%) unless otherwise indicated. NZ ¼ New
Zealand; IHD¼ ischaemic heart disease; COPD¼ chronic obstructive
pulmonary disease; SES ¼ socioeconomic status.
a One missing patient.
b Four missing patients.
Figure 1. Prevalance of abdominal aortic aneurysm stratiﬁed to
age bracket and sex (n ¼ 233) with 95% conﬁdence intervals (light
grey bars indicate women; dark grey bars indicate men).
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eight patients had either a 30 mm AAA or an abdominal
aortic graft present. Of these, 223 had a native AAA, 26 had
either a dilated prosthetic graft or a residual post-
endovascular aneurysm repair (EVAR) AAA sac 30 mm,
and nine had an aortic graft <30 mm. The CTC identiﬁed
165 (74%) new incidental AAAs; the remainder had a known
AAA on prior imaging. The median age was 79.7 years
(range 57.4e96.2 years), 74.4% were men, and 94.2% were
NZ Europeans or Europeans. A native AAA in the infrarenal
position was the most common site. Demographics and risk
factors are presented in Table 2.
The overall prevalence (95% CI) of all AAAs 30 mm was
258/3,719 (6.9%; 95% CI 6.1e7.8); after excluding 35
prosthetic AAA grafts, prevalence was 223/3,684 (6.1%;
95% CI 5.3e6.9). The prevalence of native AAA in men and
women aged 55.0e64.9, 65.0e74.9, 75.0e84.9, and 85.0
years was 1.3%, 9.1%, 16.8%, and 22.0%, and 0.4%, 2.0%,
3.9%, and 6.2% respectively (Fig. 1). The distribution of
native AAA diameter according to sex is presented in Fig. 2;
72.2% (161/223) had a 30e39-mm AAA and 10.3% (23/223)
had an AAA 50 mm.
There was a signiﬁcant association with having an AAA
and advanced age (>55 years), with an increase in preva-
lence rate of 4% (95% CI 3.0e5.0; p < .01) for each 10 year
increase. Male sex was also a strong predictor for the
presence of AAA, with a rate ratio of 4.08 (95% CI 3.1e5.4;
p < .01). In this model, deprivation indices and ethnicity
were not signiﬁcant predictors of AAA presence (Table 3).
Of the 223 patients with native AAA, 23 (10.3%) had an
AAA 50 mm, and 12 had subsequently undergone AAA
repair (nine open repair and three EVAR) during the follow
up period. Nine patients were thought not to beneﬁt from
repair: ﬁve owing to medical comorbidities (primarily
cognitive impairment), and four owing to suprarenal
extension of the aneurysm who were deemed unﬁt for
complex procedures. Two patients were on surveillance
(AAA < 55 mm). In all, 13 (56.5%) of those participants with
an AAA >50 mm were still alive at study completion. Six
died without repair, three died post-repair (>30 days post-
operatively), and one died of an AAA rupture without repair.
The median follow up period was 3.16 years (inter-
quartile range 1.23 years). Fig. 3 shows the KaplaneMeier
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Figure 2. Distribution of abdominal aortic aneurysm (AAA) size
stratiﬁed to sex (n ¼ 223). Light grey bars indicate women; dark
grey bars indicate men.
202 M. Khashram et al.survival curves for the study participants with AAA
compared with those without AAA. The 5 year observed
survival (SE) of those with AAAs was 55.1% (5.0) compared
with 77.4% (0.9) in those without AAA (log rank p < .01).
When adjusting for age and sex, the presence of AAA did
not inﬂuence late survival (HR 1.24, 95% CI 0.97e1.58;
p < 0.09) (Table 4). There were 78 deaths in the AAA
group; the causes of death during the study period were
unknown causes (n ¼ 25), cardiovascular (n ¼ 19), cancer
related (n ¼ 14), respiratory (n ¼ 11), multi-organ failure
(n ¼ 5), sepsis (n ¼ 2) and AAA rupture (n ¼ 2; both
women, with AAA diameters of 38 and 94 mm, respec-
tively). For comparison, estimated predicted life expec-
tancy ﬁgures from the NZ life tables 2010e12 were also
plotted on Fig. 3 .Table 3. Predictors of abdominal aortic aneurysm presence using a lin
Continuous variables Unadjusted
Median (IQR) Rate difference (%) 95
Age (y) 79.7 (10.3) 4.0 3.0
Deprivation index 6.0 (5.0) 0.3 0
Categorical variables n (%) Rate ratio 95
Age (y)
55e64 7.0 (0.7) 1 (ref.)
65e74 59.0 (5.0) 6.69 3.0
75e84 123.0 (9.2) 12.47 5.8
85e94 48.0 (11.9) 16.08 7.3
Sex
Male 166.0 (10.7) 4.06 3.0
Female 57.0 (2.6) 1 (ref.)
Deprivation index
1e5 91 (5.1) 1 (ref.)
6e10 132 (6.9) 1.35 1.0
Ethnicity
NZ European 210 (6.1) 1 (ref.)
Maori 4 (5.1) 0.83 0.3
Other and unknown 9 (4.8) 0.79 0.4
Note. IQR ¼ interquartile range; CI ¼ conﬁdence interval; NZ ¼ New
a Adjusted for other variables in the model.DISCUSSION
In this study, the prevalence of AAA in patients undergoing
investigation with CTC in South Island, NZ, was estimated.
The prevalence of AAAs in men aged 55 years of 6.1% is
similar to that found in a randomised controlled screening
trial conducted in Australia approximately 10 years ago.
This study speciﬁcally aimed to use CTC to determine
AAA prevalence. Previous studies reporting extra-colonic
ﬁndings from CTC varied with respect to AAA prevalence,
ranging from 1.4% to 5.0%, despite the similar de-
mographics of the groups included.13e15 In contrast to
previous studies, which did not focus primarily on the status
of the abdominal aorta, the current study represents the
largest series to date to detect AAAs speciﬁcally within a
CTC patient cohort.
In NZ, prior to a recent study, the prevalence of AAA in
the population was unknown. In the study by Majeed
et al.,16 10,403 patients undergoing a transoesophageal
echo were also examined for the presence of AAA. In men
aged 65e74 years the prevalence of AAA was 4.7%, rising to
8.5% in those aged 75e84 years.16 In the present study, CTC
was associated with similar age group speciﬁc AAA preva-
lence rates to that of those undergoing echocardiography.
Although increased AAA prevalence has been reported in
association with severe (angiographically conﬁrmed) coro-
nary artery disease,17 the large proportion of angiograph-
ically normal patients under evaluation for valvular disease
in an “echo cohort” would most likely mask a coronary
disease driven prevalance effect. In addition, some of the
differences between the echo studied population might be
due to differences in AAA measurement between CT and
US. Nevertheless, both studies highlight the burden of AAA
in NZ.ear regression model.
Adjusteda
% CI p Rate difference (%) 95% CI p
e5.0 <.01 4.0 3.0e5.0 <.01
e0.6 .08 0.2 0.1 to 0.5 .20
% CI p Rate ratio 95% CI p
e e 1 (ref.) e e
7e14.57 <.01 6.75 3.11e14.64 <.01
4e26.65 <.01 12.29 5.77e26.18 <.01
4e35.23 <.01 16.71 7.64e36.51 <.01
3e5.45 <.01 4.08 3.05e5.46 <.01
e e 1 (ref.) e e
e e 1 (ref.) e e
4e1.75 .02 1.25 0.97e1.61 .08
e e e e
2e2.18 .55 1.45 0.55e3.84 .64
1e1.51 .51 .87 0.46e1.66 .82
Zealand.
Figure 3. (A) KaplaneMeier observed (solid) and expected (dotted)
survival curves of patients with an abdominal aortic aneurysm
(AAA; black line) and without an AAA (grey line). Log rank of
observed survival p < .01. (B) Cox proportional hazard of adjusted
(age and sex) survival with dotted expected survival curves (hazard
ratio 1.24; p < .09).
Prevalence of Abdominal Aortic Aneurysm in New Zealand 203A systematic review and meta-analysis of 14 AAA
screening population studies revealed a prevalence range
of 4.2e14.2% in men and 0.35e6.2% in women.18 The
estimated prevalence in the current study is similar to
previous population studies. In the present study, 942 pa-
tients, of whom 554 (58.8%) were women, were >80 years
of age. This particular group has not been previously
included in the screening trials. This study has therefore
extended the knowledge of AAA prevalence in octogenar-
ians, a group with an improved life expectancy that has not
been included in AAA population studies. It is expected,given that the prevalence of AAA increases with age, that
more people will require management in terms of risk
factor modiﬁcation, decisions surrounding screening and
surveillance, and counselling family members for AAA
screening.
Variations with international AAA screening programmes
differ with respect to the targeted population, interval of
surveillance scans, and size prior to consideration for sur-
gical treatment.19 The epidemiology of AAA is changing
globally, with a decrease in AAA mortality observed in
countries such as England, Australia, and NZ, whereas an
increase in mortality has been reported in Hungary,
Denmark, Austria, and Romania.20 Despite a lower AAA
prevalence reported from Sweden and England, screening
for AAA remains cost-effective.21
Variations in diameter measurements between CT and
US have been reported, with CT measurements giving a
larger diameter and that this might not represent the “true”
maximal difference.22 During an US measurement, the
transducer can be tilted to measure a true diameter, even in
the presence of aortic tortuosity. However, the cardiac cycle
phase during a CT is unknown and is not routinely
controlled for. The use of CT to measure an AAA might lead
to underestimation of AAA size owing to the unknown
phase of the cardiac cycle. US measurements carry a
1.9 mm average difference between systolic and diastolic
peak recordings.23
It is unclear whether the study population is truly
representative of the general South Island, NZ, population.
A direct “cause and effect” between colorectal cancer (CRC)
and AAA prevalence has not been established; however, it
has been estimated that approximately 0.3e3.8% of AAAs
will have a concomitant CRC present at the time of the
diagnosis.24 CRC and AAA share some risk factors such as
smoking, age, and male sex. Cardiovascular risk factors for
those without an AAA and the prevalence of CRC were not
available to allow such analysis.
CT was used for AAA diagnosis, whereas the randomised
screening studies used US and in some a targeted AAA US
scan was used. The advantage of CT for screening AAA was
noted in this study with the detection of 23 isolated iliac
aneurysms, ﬁve thoracic aneurysms, two visceral aneu-
rysms, and late graft complications following AAA repair. A
study from a Veterans Affairs centre, where dedicated
vascular technicians included the iliac arteries in AAA
screening US scans, detected 0.1% of isolated iliac aneu-
rysms.25 The results of the present study revealed an iso-
lated iliac aneurysm in 23/3,719 (0.6%) patients undergoing
CTC.
Survival following elective AAA repair is lower than the
expected survival of the age and sex matched population,26
and the presence of an AAA is an independent predictor of
decreased survival. Previous studies have reported that
non-AAA related deaths are more common in patients
undergoing small AAA surveillance than AAA related
deaths.27 The current study is consistent with these ob-
servations, with the leading causes of death among patients
Table 4. Cox proportional model of variables affecting late survival.
Variable Unadjusted Adjusteda
HR 95% CI p HR 95% CI p
Age per decade 2.46 2.25e2.69 <.01 2.46 2.25e2.7 <.01
Sex (female) 0.61 0.53e0.71 <.01 0.59 0.51e0.69 <.01
Presence of AAA 2.28 1.8e2.88 <.01 1.24 0.97e1.58 .08
Deprivation index 1.02 0.99e1.06 .16 1.00 0.97e1.03 .83
Ethnicity
NZ European Ref. e e Ref. e e
Maori 0.82 0.46e1.45 .49 1.35 0.76e2.4 .30
Other and unknown 0.52 0.33e0.82 .01 0.66 0.42e1.04 .07
Note. HR ¼ hazard ratio; CI ¼ conﬁdence interval; AAA ¼ abdominal aortic aneurysm; NZ ¼ New Zealand.
a Adjusted for other variables in the model.
204 M. Khashram et al.undergoing CTC with AAA being cardiovascular and onco-
logical conditions.
Of the 4,644 patients identiﬁed in this study, 65 (1.4%) of
the AAAs detected did not have a formal diagnosis, nor was
the presence of an AAA noted during the CTC reporting
process. Such under-reporting of incidental AAA has been
observed previously in 4,112 patients undergoing CT, of
whom 53 (1.3%) did not have the aortic dilatation recog-
nised or reported.28 Based on these ﬁndings, it is recom-
mended that the abdominal aorta should be speciﬁcally
screened for an AAA when people undergo abdominal CT
scans, particularly those over the age of 55 years.
Limitations of this study were the retrospective collection
of clinical risk factors, and that the population selected
might not represent the true population as seen with lower
observed survival than expected from the total population.
In addition, some of the patients might have a reduced life
expectancy owing to a diagnosis of CRC. However, this
population sought medical attention for symptoms or clin-
ical concerns, which is different from invited participants
included in screening studies. This was also reﬂected by a
representative sample from all socioeconomic groups. It is
widely accepted that people with lower socioeconomic
status and from more deprived areas have low compliance
with AAA screening.29
In conclusion, the prevalence of AAA in a population
undergoing CTC for GI symptoms in South Island, NZ, is high
and warrants further evaluation, despite the relatively
lower percentage of men included. The results of this
observational study seem to support a national AAA
screening programme.
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